The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALPS ETF TR | ALERIAN MLP | 00162Q452 | 1,079 | 29,500 | SH | SOLE | 29,500 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 1,430 | 76,186 | SH | SOLE | 76,186 | 0 | 0 | ||
BRIDGETOWN HOLDINGS LTD | *W EXP 09/30/202 | G1355U121 | 5 | 39,773 | SH | SOLE | 39,773 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 880 | 116,884 | SH | SOLE | 116,884 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 77 | 68,297 | SH | SOLE | 68,297 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 17 | 21,333 | SH | SOLE | 21,333 | 0 | 0 | ||
LUX HEALTH TECH ACQUISITION | *W EXP 11/30/202 | 55068A118 | 9 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 1,539 | 2,052,991 | SH | SOLE | 2,052,991 | 0 | 0 | ||
PRIMAVERA CAPITAL ACQUIST CO | *W EXP 01/19/202 | G7255E117 | 2 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 3,845 | 1,403,157 | SH | SOLE | 1,403,157 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 10,690 | 6,896,551 | SH | SOLE | 6,896,551 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 4,137 | 1,723,947 | SH | SOLE | 1,723,947 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 5,696 | 15,947 | SH | SOLE | 15,947 | 0 | 0 | ||
SPDR SER TR | S&P OILGAS EXP | 78468R556 | 2,183 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
UNITED STS OIL FD LP | UNITS | 91232N207 | 11,326 | 173,500 | SH | Call | SOLE | 173,500 | 0 | 0 | |
VECTIVBIO HLDG AG | ORD SHS | H9060V101 | 845 | 140,863 | SH | SOLE | 140,863 | 0 | 0 | ||
XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 9,421 | 6,039,028 | SH | SOLE | 6,039,028 | 0 | 0 |